LRRK2 Cohort Consortium
The LRRK2 Cohort Consortium, funded by the Michael J. Fox Foundation, brought research groups together to speed efforts to move LRRK2 toward therapeutic relevance for patients. The CTSDMC served as...
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention (MedFocus) is a multi-center, cluster-randomized study using a centralized cardiovascular risk service (CVSR) in...
NeuroNEXT
The Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) was created to conduct studies of treatments for neurological diseases through partnerships with academia, private foundations,...
NILO-PD
Funded by the Michael J. Fox Foundation, NILO-PD is a Phase II clinical trial to evaluate the safety and tolerability of nilotinib in Parkinson's disease. The CTSDMC is the statistical core for this...
NTM INFEcT
Funded by the Center for Disease Control (CDC), NTM INFEcT is a registry of persons infected with nontuberculous mycobacteria (NTM) after exposure to hearter cooler units during cardiothoracic...
Parkinson's Progression Markers Initiative (PPMI)
The Parkinson's Progression Markers Initiative (PPMI), funded by the Michael J. Fox Foundation, is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest...
PPMI Data Managment Core
The Parkinson's Progression Markers Initiative (PPMI), funded by the Michael J. Fox Foundation, is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest...
PPMI Statistics Core
The Parkinson's Progression Markers Initiative (PPMI), funded by the Michael J. Fox Foundation, is a landmark observational clinical study to comprehensively evaluate cohorts of significant interest...
Placebo-Controlled Trial of Sertraline and IPT for Postpartum Depression (IPT)
The purpose of this study was to test the efficacy of sertraline and Interpersonal Psychotherapy (IPT) relative to pill placebo in a two site randomized controlled trial over a period of 12 weeks. It...